Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-31

Clinical Trial Update: A Prospective Clinical Study to Evaluate the Effectiveness and Safety of Xcell Amnio MatrixTM (XAM) in the Management of Chronic Non-healing DFUs [NA]

View source ↗

Summary

A prospective clinical study is evaluating the effectiveness and safety of Xcell Amnio Matrix (XAM) for chronic non-healing diabetic foot ulcers, with recruitme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Xcell Amnio Matrix (amniotic membrane matrix)

Snippet

Sponsor: New Horizon Medical Solutions | Conditions: Diabetic Foot Ulcer (DFU) | NA | Status: RECRUITING